ICCM ICCM
Company Profile ↓Company Overview
ICCM (ICCM) is a publicly traded company listed on with a market capitalization of $7.82M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -88.10% |
| 6 Months: | -82.46% |
| 3 Months: | -62.46% |
| 1 Month: | -23.21% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)43.13 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 91.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 725.00K | 525.00K | 850.00K | 1.28M | 911.00K |
| Cost of Revenue | - | 507.00K | 394.00K | 573.00K | 679.00K | 616.00K |
| Gross Profit | - | 218.00K | 131.00K | 277.00K | 600.00K | 295.00K |
| Operating Expenses | - | 3.88M | 3.52M | 4.11M | 4.82M | 4.54M |
| Operating Income | - | -3.66M | -3.38M | -3.84M | -4.22M | -4.25M |
| EBITDA | - | -3.57M | -3.32M | -3.76M | -4.14M | -4.18M |
| Interest Expense | - | - | - | - | - | - |
| Pretax Income | - | -3.59M | -3.36M | -3.86M | -4.25M | -4.27M |
| Tax Provision | - | - | - | - | - | - |
| Net Income | - | -3.59M | -3.36M | -3.86M | -4.25M | -4.27M |
| Diluted EPS | - | -1.80 | - | - | - | -1.80 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 30.19M | 16.41M | 12.58M | 13.89M |
| Current Assets | - | 28.13M | 14.18M | 10.75M | 12.61M |
| Cash & Equivalents | - | 23.66M | 10.53M | 7.56M | 8.90M |
| Inventory | - | 2.86M | 2.27M | 1.99M | 2.62M |
| Receivables | - | 78.00K | 103.00K | 221.00K | 331.00K |
| Total Liabilities | - | 4.77M | 4.25M | 5.67M | 4.84M |
| Current Liabilities | - | 4.34M | 3.87M | 5.51M | 4.82M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 597.00K | 599.00K | 459.00K | 217.00K |
| Total Equity | - | 25.42M | 12.16M | 6.90M | 9.05M |
| Shares Outstanding | - | 1.55M | 1.55M | 1.92M | 2.44M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -14.29M | -12.55M | -12.56M | -14.57M |
| Investing Cash Flow | - | -891.00K | -684.00K | 446.00K | -36.00K |
| Financing Cash Flow | - | 13.58M | 83.00K | 9.19M | 15.83M |
| Capital Expenditure | - | -891.00K | -480.00K | -71.00K | -36.00K |
| Free Cash Flow | - | -15.18M | -13.03M | -12.63M | -14.61M |
| Net Change in Cash | - | -1.61M | -13.15M | -2.93M | 1.22M |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ICCM
IceCure Medical Will Discuss Six-Month Results on Aug. 12 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNXzhEVmRCTjdOd0ROeDhib29BTlYyWjJHSExYYjlWMVVNcDZtMXFuNXo1V1F0Y0s4dEpQSm5OVnpPWXV1WGdmc1NFR21CaUtreFBuekRvQU5SdWl2NnlTLTNsNmxObWJsY2RMVGNlSkZLb001Z01OQXZld2FyQzQ1U01lanREMDl3Zi1xMV…
IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance - PR Newswire
<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxNS0ZVb2NPS1JLN3IxX21LNFllQ1BKZHlIbFdOYmpDVDNnbldkOHNrWVROZFNKRnZuRUNxWjdxRWtETzlCNTBYNGRhZ1J0REU1ME9WdkxuREJoaEtpLWdsR1lfeDlYMGkwYXZBYmlWWVlFSHVKX3lWZUp6ZGg1dEtuaG5ka01kSGxKaE1HVC…
IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPdWJ5cEkzd2NzSUwtRDJfOC1KRGl2Z241MzNTOGwwVU0yUURIUjVBUkdVS0stV2pSenduRDBjeTlTVTVXWXBzellEWG9BN0dOQWdVUm02aWtoT3d1QXlQX3FHeTA5bjBSMi0wdWhUeENNUGpsTFlkdm9fOGVKOHV0bTEtM01PeG5NUXlCZV…
IceCure Stock Surges After 70% ProSense Install Increase - Icecure Medical (NASDAQ:ICCM) - Benzinga
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNSXFPOFRHSkY1YTE2a29wdXdDRTgzbGJkUjdLQ04tZ05ZZmhZN3B0VTltd1pTY0o1Ym9WSnp0ckJZYTNsQTFpZjl6MmI2alBxZEZfVmN1S1lkdUc2RWxPOW9WY2dIdFQ1NC1sNGRXMFF5ZU9xMWdRbUVXRzZrTEZTNi0zX19ab1ZTWG9idk…
ICCM Stock Soars As ProSense Adoption And Funding Fuel Momentum - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTE15Rzd2UVN4YVJKenVHVE01MG5LY0hsRE9mMVduN1lWcWI0YjRxTnBBZUphTFNsS3BVVTA3Vl9DVnJNd2ozOEo5SElkaVJ3eUFLV3ZrX21IMnE3QXVjMXdfVU5FQlBuZkppeml1WjJJN0Z1UEpPeEhiUFRsVWU?oc=5" target="_blank">…
ICCM Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE5FRHlnM1RxZmdJNnhpN0dCakxxU0FpUE1wTWU0VUYwbWR3Z3l4S1phT3ZxaEJsaVdNVHR1amx5WEhYbm9pcEtncjRELU9YSjluUFBFVzJucnJWOHpadUdVUGdTclVxeUNaY0J5eXEwZUU0ZUpZMlBfOFVn?oc=5" target="_blank">ICC…
ICCM — Frequently Asked Questions
What is the current share price of ICCM?
As of 2026-08-05 17:25 PDT, ICCM trades at $3.21 on NASDAQ/NYSE. Its 52-week range is $2.13 to $35.70.
What is the market capitalisation of ICCM?
ICCM has a market capitalisation of $7.82M on NASDAQ/NYSE.
Is ICCM a good stock to buy?
This page provides a data-driven analysis of ICCM, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.